{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T10:49:13Z","timestamp":1782816553645,"version":"3.54.5"},"reference-count":170,"publisher":"Ubiquity Press, Ltd.","issue":"1","funder":[{"name":"Strategic Health Innovation Partnership","award":["SHIP-RFA-01-2019"],"award-info":[{"award-number":["SHIP-RFA-01-2019"]}]},{"name":"RCD, NRF UID","award":["120812"],"award-info":[{"award-number":["120812"]}]},{"name":"BRIP","award":["120812"],"award-info":[{"award-number":["120812"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,22]]},"DOI":"10.5334\/gh.1191","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T06:08:16Z","timestamp":1679465296000},"source":"Crossref","is-referenced-by-count":7,"title":["Measurement Tools and Utility of Hair Analysis for Screening Adherence to Antihypertensive Medication"],"prefix":"10.5334","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9757-4048","authenticated-orcid":false,"given":"Jyoti R.","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5965-3610","authenticated-orcid":false,"given":"Phiwayinkosi V.","family":"Dludla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6328-0789","authenticated-orcid":false,"given":"Rabia","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3285","reference":[{"issue":"8","key":"key20230322060814_B1","article-title":"Estimating the prevalence and awareness rates of hypertension in Africa: a systematic analysis","volume":"9","year":"2014","journal-title":"PLOS One"},{"key":"key20230322060814_B2","author":"World Health Organization","year":"2014"},{"issue":"2","key":"key20230322060814_B3","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1080\/20786204.2012.10874203","article-title":"Lifestyle changes for hypertension: SA Hypertension Society Supplement","volume":"54","year":"2012","journal-title":"South African Family Practice"},{"issue":"6","key":"key20230322060814_B4","doi-asserted-by":"crossref","first-page":"922","DOI":"10.4103\/2141-9248.144914","article-title":"Determinants of patient\u2019s adherence to hypertension medications: Application of health belief model among rural patients","volume":"4","year":"2014","journal-title":"Annals of Medical and Health Sciences Research"},{"issue":"6","key":"key20230322060814_B5","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/HYPERTENSIONAHA.108.189141","article-title":"Resistant hypertension: Diagnosis, evaluation, and treatment: A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research","volume":"51","year":"2008","journal-title":"Hypertension"},{"issue":"1","key":"key20230322060814_B6","first-page":"1","article-title":"Adherence to antihypertensive treatment and associated factors among patients on follow up at University of Gondar Hospital, Northwest Ethiopia","volume":"12","year":"2012","journal-title":"BMC Public Health"},{"issue":"11","key":"key20230322060814_B7","first-page":"1","article-title":"Is there any hope for monitoring adherence in an efficient and feasible way for resistant hypertension diagnosis and follow-up?","volume":"22","year":"2020","journal-title":"Current Hypertension Reports"},{"issue":"6","key":"key20230322060814_B8","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/jch.13874","article-title":"Hypertension control in sub-Saharan Africa: Clinical inertia is another elephant in the room","volume":"22","year":"2020","journal-title":"Journal of Clinical Hypertension (Greenwich"},{"key":"key20230322060814_B9","first-page":"1281384","article-title":"Prevalence, risk factors, awareness, and treatment and control of hypertension in Mafia Island, Tanzania","volume":"2016","year":"2016","journal-title":"International Journal of Hypertension"},{"issue":"1","key":"key20230322060814_B10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/jhh.2016.31","article-title":"Non-adherence to anti-hypertensive medication in low- and middle-income countries: A systematic review and meta-analysis of 92443 subjects","volume":"31","year":"2017","journal-title":"Journal of Human Hypertension"},{"key":"key20230322060814_B11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-3-319-76593-8_2","volume-title":"Drug adherence in hypertension and cardiovascular protection","year":"2018"},{"issue":"5","key":"key20230322060814_B12","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jval.2013.03.1631","article-title":"Impact of interventions on medication adherence and blood pressure control in patients with essential hypertension: A systematic review by the ISPOR medication adherence and persistence special interest group","volume":"16","year":"2013","journal-title":"Value in Health"},{"issue":"1","key":"key20230322060814_B13","first-page":"e1","article-title":"Medication adherence and blood pressure control: A scientific statement from the American Heart Association","volume":"79","year":"2022","journal-title":"Hypertension"},{"issue":"6","key":"key20230322060814_B14","article-title":"Factors influencing poor medication adherence amongst patients with chronic disease in low- and-middle-income countries: A systematic scoping review","volume":"8","year":"2022","journal-title":"Heliyon"},{"issue":"3","key":"key20230322060814_B15","first-page":"189","article-title":"The challenge of patient adherence","volume":"1","year":"2005","journal-title":"Therapeutics and Clinical Risk Management"},{"key":"key20230322060814_B16","first-page":"35","article-title":"Adherence and health care costs","volume":"7","year":"2014","journal-title":"Risk Management and Healthcare Policy"},{"issue":"2","key":"key20230322060814_B17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5830\/CVJA-2018-050","article-title":"Assessment of adherence to medication for cardiovascular diseases: measurement tools","volume":"30","year":"2019","journal-title":"Cardiovascular Journal of Africa"},{"issue":"9142","key":"key20230322060814_B18","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(05)79831-7","article-title":"Indinavir concentrations in hair from patients receiving highly active antiretroviral therapy","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"8","key":"key20230322060814_B19","doi-asserted-by":"crossref","first-page":"656","DOI":"10.7326\/0003-4819-137-8-200210150-00009","article-title":"Relationship between levels of indinavir in hair and virologic response to highly active antiretroviral therapy","volume":"137","year":"2002","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"key20230322060814_B20","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/QAD.0b013e328325a4a9","article-title":"Protease inhibitor levels in hair samples strongly predict virologic responses to HIV treatment","volume":"23","year":"2009","journal-title":"AIDS (London, England"},{"issue":"5","key":"key20230322060814_B21","first-page":"658","article-title":"Evidence of 2 populations of mephedrone abusers by hair testing. Application to 4 forensic expertises","volume":"15","year":"2017","journal-title":"Current Neuropharmacology"},{"key":"key20230322060814_B22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-3-642-25611-0_2","volume-title":"Chemical and physical behavior of human hair","year":"2012"},{"issue":"2","key":"key20230322060814_B23","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/QAI.0000000000001993","article-title":"Measuring adherence to antiretroviral therapy via hair concentrations in India","volume":"81","year":"2019","journal-title":"Journal of Acquired Immune Deficiency Syndromes (1999"},{"issue":"10","key":"key20230322060814_B24","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/dta.3346","article-title":"Hair analysis for beta-blockers and calcium-channel blockers by using liquid chromatography-tandem mass spectrometry as a tool for monitoring adherence to antihypertensive therapy","volume":"14","year":"2022","journal-title":"Drug Testing Analysis"},{"key":"key20230322060814_B25","first-page":"217047","article-title":"Medication adherence measures: An overview","year":"2015","journal-title":"BioMed Research International"},{"issue":"1","key":"key20230322060814_B26","first-page":"1","article-title":"Physician assessments of medication adherence and decisions to intensify medications for patients with uncontrolled blood pressure: Still no better than a coin toss","volume":"12","year":"2012","journal-title":"BMC Health Services Research"},{"issue":"1","key":"key20230322060814_B27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/13548506.2019.1619788","article-title":"A qualitative comparison of high and low adherers with apparent treatment-resistant hypertension","volume":"25","year":"2020","journal-title":"Psychology, Health & Medicine"},{"issue":"3","key":"key20230322060814_B28","article-title":"Factors influencing long-term medication non-adherence among diabetes and hypertensive patients in Ghana: A qualitative investigation","volume":"13","year":"2018","journal-title":"PLOS One"},{"issue":"2","key":"key20230322060814_B29","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/HJH.0000000000001877","article-title":"Patients\u2019 and healthcare providers\u2019 perceptions and practices regarding hypertension, pharmacy-based care, and mHealth in Lagos, Nigeria: A mixed methods study","volume":"37","year":"2019","journal-title":"Journal of Hypertension"},{"issue":"1","key":"key20230322060814_B30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5334\/aogh.2904","article-title":"Adherence to antihypertensive medication: An interview analysis of southwest Ugandan patients\u2019 perspectives","volume":"86","year":"2020","journal-title":"Annals of Global Health"},{"issue":"1","key":"key20230322060814_B31","first-page":"E1","article-title":"Blood pressure control amongst patients living with hypertension presenting to an urban district hospital outpatient clinic in Kwazulu-Natal","volume":"6","year":"2014","journal-title":"African Journal of Primary Health Care & Family Medicine"},{"issue":"2","key":"key20230322060814_B32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1345\/aph.1D252","article-title":"Measurement, correlates, and health outcomes of medication adherence among seniors","volume":"38","year":"2004","journal-title":"Annals of Pharmacotherapy"},{"issue":"9","key":"key20230322060814_B33","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1291\/hypres.31.1765","article-title":"Physicians\u2019 ability to predict patients\u2019 adherence to antihypertensive medication in primary care","volume":"31","year":"2008","journal-title":"Hypertension Research"},{"issue":"2","key":"key20230322060814_B34","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1161\/HYPERTENSIONAHA.113.00687","article-title":"Measuring, analyzing, and managing drug adherence in resistant hypertension","volume":"62","year":"2013","journal-title":"Hypertension"},{"issue":"6","key":"key20230322060814_B35","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/01.hjh.0000170390.07321.ca","article-title":"Is interview a reliable method to verify the compliance with antihypertensive therapy? An international central-European study","volume":"23","year":"2005","journal-title":"Journal of Hypertension"},{"key":"key20230322060814_B36","first-page":"569","article-title":"Identification of validated questionnaires to measure adherence to pharmacological antihypertensive treatments","volume":"9","year":"2015","journal-title":"Patient Preference and Adherence"},{"key":"key20230322060814_B37","first-page":"67","article-title":"Concurrent and predictive validity of a self-reported measure of medication adherence","year":"1986","journal-title":"Medical Care"},{"issue":"3","key":"key20230322060814_B38","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1751-7117.2000.tb00211.x","article-title":"Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale","volume":"15","year":"2000","journal-title":"Progress in Cardiovascular Nursing"},{"issue":"6","key":"key20230322060814_B39","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jclinepi.2005.10.013","article-title":"Adherence to antihypertensive medication assessed by self-report was associated with electronic monitoring compliance","volume":"59","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7","key":"key20230322060814_B40","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0149-2918(00)80058-2","article-title":"Stages of change for adherence with medication regimens for chronic disease: Development and validation of a measure","volume":"22","year":"2000","journal-title":"Clinical Therapeutics"},{"issue":"2","key":"key20230322060814_B41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0738-3991(98)00107-4","article-title":"The Brief Medication Questionnaire: A tool for screening patient adherence and barriers to adherence","volume":"37","year":"1999","journal-title":"Patient Education and Counseling"},{"issue":"1","key":"key20230322060814_B42","first-page":"55","article-title":"From Morisky to Hill-Bone; self-reports scales for measuring adherence to medication","volume":"38","year":"2014","journal-title":"Collegium Antropologicum"},{"issue":"3","key":"key20230322060814_B43","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1474-5151(03)00058-6","article-title":"Measuring adherence in a hypertension clinical trial","volume":"2","year":"2003","journal-title":"European Journal of Cardiovascular Nursing"},{"issue":"5","key":"key20230322060814_B44","first-page":"565","article-title":"Assessing adherence to antihypertensive therapy in primary health care in Namibia: Findings and implications","volume":"31","year":"2017","journal-title":"Cardiovascular Drugs and Therapy"},{"issue":"3","key":"key20230322060814_B45","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.4314\/ahs.v20i3.42","article-title":"Adherence to drug therapy among hypertensive patients attending two district hospitals in Ghana","volume":"20","year":"2020","journal-title":"African Health Sciences"},{"issue":"2","key":"key20230322060814_B46","first-page":"243","article-title":"Patient education and medication adherence among hypertensives in a tertiary hospital, South Western Nigeria","volume":"30","year":"2020","journal-title":"Ethiopian Journal of Health Sciences"},{"key":"key20230322060814_B47","first-page":"27","article-title":"Depression and medication-adherence in patients with hypertension attending a tertiary health facility in South-West Nigeria","volume":"33","year":"2019","journal-title":"Pan African Medical Journal"},{"issue":"1","key":"key20230322060814_B48","first-page":"1","article-title":"Drug adherence for antihypertensive medications and its determinants among adult hypertensive patients attending in chronic clinics of referral hospitals in Northwest Ethiopia","volume":"18","year":"2017","journal-title":"BMC Pharmacology and Toxicology"},{"issue":"1","key":"key20230322060814_B49","first-page":"1","article-title":"Poor drug adherence and lack of awareness of hypertension among hypertensive stroke patients in Kampala, Uganda: A cross sectional study","volume":"9","year":"2016","journal-title":"BMC Research Notes"},{"issue":"6\u20137","key":"key20230322060814_B50","first-page":"433","article-title":"Poor adherence to medication and salt restriction as a barrier to reaching blood pressure control in patients with hypertension: Cross-sectional study from 12 sub-Saharan countries","volume":"113","year":"2020","journal-title":"Archives of Cardiovascular Diseases"},{"issue":"7","key":"key20230322060814_B51","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1751-7176.2012.00634.x","article-title":"Validation of a French version of the 8-item Morisky Medication Adherence Scale in hypertensive adults","volume":"14","year":"2012","journal-title":"Journal of Clinical Hypertension"},{"issue":"4","key":"key20230322060814_B52","article-title":"Nonadherence to antihypertensive drugs: A systematic review and meta-analysis","volume":"96","year":"2017","journal-title":"Medicine"},{"issue":"1","key":"key20230322060814_B53","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/npmj.npmj_147_18","article-title":"Medication adherence and 24-h blood pressure in apparently uncontrolled hypertensive Nigerian patients","volume":"26","year":"2019","journal-title":"Nigerian Postgraduate Medical Journal"},{"key":"key20230322060814_B54","first-page":"27","article-title":"Depression and medication-adherence in patients with hypertension attending a tertiary health facility in south-west Nigeria","volume":"33","year":"2019","journal-title":"Pan African Medical Journal"},{"issue":"2","key":"key20230322060814_B55","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4103\/npmj.npmj_48_19","article-title":"Medication adherence and patient satisfaction among hypertensive patients attending outpatient clinic in Lagos University Teaching Hospital, Nigeria","volume":"26","year":"2019","journal-title":"Nigerian Postgraduate Medical Journal"},{"issue":"1","key":"key20230322060814_B56","first-page":"1","article-title":"Treatment adherence and blood pressure outcome among hypertensive out-patients in two tertiary hospitals in Sokoto, Northwestern Nigeria","volume":"18","year":"2018","journal-title":"BMC Cardiovascular Disorders"},{"issue":"1","key":"key20230322060814_B57","first-page":"e1","article-title":"Knowledge, adherence and control among patients with hypertension attending a peri-urban primary health care clinic, KwaZulu-Natal","volume":"9","year":"2017","journal-title":"African Journal of Primary Health Care & Family Medicine"},{"issue":"1","key":"key20230322060814_B58","first-page":"286","article-title":"Cross-cultural validation of the Hill-Bone Compliance to High Blood Pressure Therapy Scale in a South African, primary healthcare setting","volume":"16","year":"2006","journal-title":"Ethnicity and Disease"},{"issue":"3","key":"key20230322060814_B59","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jclinepi.2009.06.011","article-title":"Comparison of two self-rating instruments for medication adherence assessment in hypertension revealed insufficient psychometric properties","volume":"63","year":"2010","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"key20230322060814_B60","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/13814780903452150","article-title":"Validity and reliability of the Turkish version of the Hill-Bone Compliance to High Blood Pressure Therapy Scale for use in primary health care settings","volume":"15","year":"2009","journal-title":"European Journal of General Practice"},{"issue":"5","key":"key20230322060814_B61","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"key20230322060814_B62","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jash.2015.04.004","article-title":"Comparison of Morisky Medication Adherence Scale with therapeutic drug monitoring in apparent treatment-resistant hypertension","volume":"9","year":"2015","journal-title":"Journal of the American Society of Hypertension"},{"issue":"6","key":"key20230322060814_B63","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/HJH.0000000000001299","article-title":"Drug adherence in hypertension: From methodological issues to cardiovascular outcomes","volume":"35","year":"2017","journal-title":"Journal of Hypertension"},{"issue":"3","key":"key20230322060814_B64","first-page":"5","article-title":"Review of the four item Morisky Medication Adherence Scale (MMAS-4) and eight item Morisky Medication Adherence Scale (MMAS-8)","volume":"5","year":"2014","journal-title":"INNOVATIONS in Pharmacy"},{"issue":"3","key":"key20230322060814_B65","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.sapharm.2013.10.006","article-title":"The 8-item Morisky Medication Adherence Scale: Validation of a Brazilian-Portuguese version in hypertensive adults","volume":"10","year":"2014","journal-title":"Research in Social & Administrative Pharmacy"},{"issue":"5","key":"key20230322060814_B66","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1751-7176.2008.07572.x","article-title":"Predictive validity of a medication adherence measure in an outpatient setting","volume":"10","year":"2008","journal-title":"Journal of Clinical Hypertens (Greenwich)"},{"issue":"3","key":"key20230322060814_B67","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00000441-200509000-00006","article-title":"Reliability of a medication adherence measure in an outpatient setting","volume":"330","year":"2005","journal-title":"The American Journal of the Medical Sciences"},{"key":"key20230322060814_B68","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1590\/S0034-89102012005000013","article-title":"Teste de Morisky-Green e Brief Medication Questionnaire para avaliar ades\u00e3o a medicamentos","volume":"46","year":"2012","journal-title":"Revista de Sa\u00fade P\u00fablica"},{"key":"key20230322060814_B69","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.2147\/PPA.S268031","article-title":"The translation, reliability and validity of the Chinese version of the Hill-Bone Compliance to High Blood Pressure Therapy Scale in adults with hypertension","volume":"14","year":"2020","journal-title":"Patient Preference and Adherence"},{"issue":"1","key":"key20230322060814_B70","first-page":"286","article-title":"Cross-cultural validation of the Hill-Bone Compliance to High Blood Pressure Therapy Scale in a South African, primary healthcare setting","volume":"16","year":"2006","journal-title":"Ethnicity & Disease"},{"issue":"3","key":"key20230322060814_B71","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jclinepi.2007.04.007","article-title":"An adherence self-report questionnaire facilitated the differentiation between nonadherence and nonresponse to antihypertensive treatment","volume":"61","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"key20230322060814_B72","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejcnurse.2008.10.006","article-title":"Reliability and validity of the Turkish adaptation of medication adherence self-efficacy scale in hypertensive patients","volume":"8","year":"2009","journal-title":"European Journal of Cardiovascular Nursing"},{"issue":"9","key":"key20230322060814_B73","doi-asserted-by":"crossref","first-page":"905","DOI":"10.18553\/jmcp.2014.20.9.905","article-title":"Impact of a pill box clinic to improve systolic blood pressure in veterans with uncontrolled hypertension taking 3 or more antihypertensive medications","volume":"20","year":"2014","journal-title":"Journal of Managed Care & Specialty Pharmacy"},{"issue":"4 Suppl","key":"key20230322060814_B74","first-page":"34s","article-title":"Appointment attendance, pill counts, and achievement of goal blood pressure in the African American Study of Kidney Disease and Hypertension Pilot Study","volume":"17","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"Suppl 2","key":"key20230322060814_B75","first-page":"141","article-title":"Relationship between drug compliance and degree of control in patients with hypertension, diabetes or dyslipidemia","volume":"116","year":"2001","journal-title":"Medicina cl\u00ednica (Barc)"},{"issue":"6","key":"key20230322060814_B76","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/ajh\/hpv185","article-title":"Drug side effect symptoms and adherence to antihypertensive medication","volume":"29","year":"2016","journal-title":"American Journal of Hypertension"},{"issue":"1","key":"key20230322060814_B77","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/HJH.0b013e32835b0842","article-title":"The Nigerian anti-hypertensive adherence trial (NA-HAT): A community-based randomized trial","volume":"31","year":"2013","journal-title":"Journal of Hypertension"},{"issue":"1","key":"key20230322060814_B78","first-page":"100","article-title":"Drug compliance among hypertensive patients in Kassala, eastern Sudan","volume":"6","year":"2000","journal-title":"Eastern Mediterranean Health Journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit"},{"issue":"9","key":"key20230322060814_B79","first-page":"539","article-title":"Medication compliance among Tanzanian hypertensives","volume":"74","year":"1997","journal-title":"East African Medical Journal"},{"issue":"12","key":"key20230322060814_B80","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.18553\/jmcp.2014.20.12.1217","article-title":"Magnitude of pharmacological nonadherence in hypertensive patients taking antihypertensive medication from a community pharmacy in Spain","volume":"20","year":"2014","journal-title":"Journal of Managed Care Pharmacy"},{"issue":"2","key":"key20230322060814_B81","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ajh.2009.207","article-title":"Assessing medication adherence simultaneously by electronic monitoring and pill count in patients with mild-to-moderate hypertension","volume":"23","year":"2010","journal-title":"American Journal of Hypertension"},{"issue":"6","key":"key20230322060814_B82","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/clpt.2014.59","article-title":"Methods for measuring, enhancing, and accounting for medication adherence in clinical trials","volume":"95","year":"2014","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"1","key":"key20230322060814_B83","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1161\/HYPERTENSIONAHA.109.132423","article-title":"Hypertension prevalence, awareness, treatment, and control in Mozambique: Urban\/rural gap during epidemiological transition","volume":"54","year":"2009","journal-title":"Hypertension"},{"issue":"2","key":"key20230322060814_B84","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00004872-200102000-00022","article-title":"Electronic compliance monitoring in resistant hypertension: The basis for rational therapeutic decisions","volume":"19","year":"2001","journal-title":"Journal of Hypertension"},{"key":"key20230322060814_B85","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.aca.2019.04.026","article-title":"Development and application of a LC-HRMS\/MS method for analyzing antihypertensive drugs in oral fluid for monitoring drug adherence","volume":"1070","year":"2019","journal-title":"Analytica chimica acta"},{"issue":"8","key":"key20230322060814_B86","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jamainternmed.2017.2449","article-title":"Effect of electronic reminders, financial incentives, and social support on outcomes after myocardial infarction: The HeartStrong randomized clinical trial","volume":"177","year":"2017","journal-title":"JAMA Internal Medicine"},{"issue":"2","key":"key20230322060814_B87","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.amjhyper.2006.07.018","article-title":"Electronic monitoring of adherence as a tool to improve blood pressure control. A randomized controlled trial","volume":"20","year":"2007","journal-title":"American Journal of Hypertension"},{"issue":"10","key":"key20230322060814_B88","first-page":"914","article-title":"Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: A randomized clinical trial using electronic monitoring","volume":"13","year":"1997","journal-title":"Canadian Journal of Cardiology"},{"key":"key20230322060814_B89","article-title":"Importance of the directly observed treatment intake on the approach of patients with resistant hypertension","volume":"36","year":"2018","journal-title":"Journal of Hypertension"},{"issue":"10","key":"key20230322060814_B90","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jamainternmed.2019.1455","article-title":"Use of directly observed therapy to assess treatment adherence in patients with apparent treatment-resistant hypertension","volume":"179","year":"2019","journal-title":"JAMA Internal Medicine"},{"issue":"4","key":"key20230322060814_B91","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/08037051.2015.1121706","article-title":"Adherence to medication and drug monitoring in apparent treatment-resistant hypertension","volume":"25","year":"2016","journal-title":"Blood Press"},{"issue":"24","key":"key20230322060814_B92","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1136\/heartjnl-2022-320802","article-title":"Directly observed therapy for resistant\/refractory hypertension diagnosis and blood pressure control","volume":"108","year":"2022","journal-title":"Heart"},{"issue":"2","key":"key20230322060814_B93","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/jhh.2015.38","article-title":"Non-adherence to antihypertensive medication is very common among resistant hypertensives: Results of a directly observed therapy clinic","volume":"30","year":"2016","journal-title":"Journal of Human Hypertension"},{"issue":"1","key":"key20230322060814_B94","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/hr.2010.183","article-title":"Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non-responsiveness from non-adherence to recommended therapy","volume":"34","year":"2011","journal-title":"Hypertension Research"},{"issue":"12","key":"key20230322060814_B95","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1097\/HJH.0b013e3283652c61","article-title":"Precise assessment of noncompliance with the antihypertensive therapy in patients with resistant hypertension using toxicological serum analysis","volume":"31","year":"2013","journal-title":"Journal of Hypertension"},{"issue":"1\u20132","key":"key20230322060814_B96","first-page":"65","article-title":"Assessment of adherence to treatment in patients with resistant hypertension using toxicological serum analysis","volume":"125","year":"2015","journal-title":"Polskie Archiwum Medycyny Wewne\u0328trznej"},{"issue":"5","key":"key20230322060814_B97","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1515\/cclm-2019-0820","article-title":"Hyphenated mass spectrometry techniques for assessing medication adherence: advantages, challenges, clinical applications and future perspectives","volume":"58","year":"2020","journal-title":"Clinical Chemistry and Laboratory Medicine (CCLM)"},{"issue":"1","key":"key20230322060814_B98","first-page":"137","article-title":"Benefits of electronic pillboxes in evaluating treatment compliance of patients with mild to moderate hypertension","volume":"14","year":"1996","journal-title":"Journal of Hypertension"},{"issue":"11","key":"key20230322060814_B99","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1007\/s11606-019-05241-x","article-title":"Electronic pill bottles or bidirectional text messaging to improve hypertension medication adherence (Way 2 Text): A randomized clinical trial","volume":"34","year":"2019","journal-title":"Journal of General Internal Medicine"},{"issue":"4","key":"key20230322060814_B100","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/HJH.0b013e32835e2286","article-title":"Resistant hypertension? Assessment of adherence by toxicological urine analysis","volume":"31","year":"2013","journal-title":"Journal of Hypertension"},{"issue":"5","key":"key20230322060814_B101","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/HYPERTENSIONAHA.117.09631","article-title":"Biochemical screening for nonadherence is associated with blood pressure reduction and improvement in adherence","volume":"70","year":"2017","journal-title":"Hypertension"},{"issue":"6","key":"key20230322060814_B102","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0149-2918(99)80026-5","article-title":"Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice","volume":"21","year":"1999","journal-title":"Clinical Therapeutics"},{"issue":"2","key":"key20230322060814_B103","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ajh.2009.207","article-title":"Assessing medication adherence simultaneously by electronic monitoring and pill count in patients with mild-to-moderate hypertension","volume":"23","year":"2010","journal-title":"American Journal of Hypertension"},{"issue":"3, Pt 1","key":"key20230322060814_B104","first-page":"309","article-title":"Pill count measures of compliance in a drug trial: Variability and suitability","volume":"1","year":"1988","journal-title":"American Journal of Hypertension"},{"issue":"22","key":"key20230322060814_B105","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1001\/jama.1989.03420220087032","article-title":"How often is medication taken as prescribed? A novel assessment technique","volume":"261","year":"1989","journal-title":"JAMA"},{"issue":"2","key":"key20230322060814_B106","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/clpt.1989.121","article-title":"Time to stop counting the tablets?","volume":"46","year":"1989","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"11","key":"key20230322060814_B107","first-page":"CD000011","article-title":"Interventions for enhancing medication adherence","volume":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"key20230322060814_B108","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s40265-013-0041-3","article-title":"Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: A systematic literature review and meta-analysis","volume":"73","year":"2013","journal-title":"Drugs"},{"issue":"3","key":"key20230322060814_B109","doi-asserted-by":"crossref","first-page":"239","DOI":"10.18553\/jmcp.2006.12.3.239","article-title":"Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations","volume":"12","year":"2006","journal-title":"Journal of Managed Care Pharmacy"},{"issue":"1","key":"key20230322060814_B110","first-page":"S75","article-title":"Compliance, electronic monitoring and antihypertensive drugs","volume":"16","year":"1998","journal-title":"Journal of Hypertension Supplement: Official Journal of the International Society of Hypertension"},{"issue":"1","key":"key20230322060814_B111","first-page":"33","article-title":"Monitoring one-year compliance to antihypertension medication in the Seychelles","volume":"80","year":"2002","journal-title":"Bulletin of the World Health Organization"},{"issue":"3","key":"key20230322060814_B112","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/08037051.2012.679029","article-title":"Evaluation of the correlation between self-report and electronic monitoring of adherence to hypertension therapy","volume":"21","year":"2012","journal-title":"Blood Pressure"},{"key":"key20230322060814_B113","first-page":"91","article-title":"Determinants of patient adherence: A review of systematic reviews","volume":"4","year":"2013","journal-title":"Frontiers in Pharmacology"},{"issue":"7","key":"key20230322060814_B114","article-title":"Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies","volume":"15","year":"2018","journal-title":"PLOS medicine"},{"issue":"2","key":"key20230322060814_B115","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/tcmj.tcmj_177_18","article-title":"Improving the assessment of medication adherence: Challenges and considerations with a focus on low-resource settings","volume":"31","year":"2019","journal-title":"Tzu-Chi Medical Journal"},{"key":"key20230322060814_B116","article-title":"Directly observed administration of antihypertensive medication prior to ambulatory blood pressure monitoring\u2014A useful tool for investigating \u201cresistant hypertension.\u201d","volume":"39","year":"2021","journal-title":"Journal of Hypertension"},{"issue":"6","key":"key20230322060814_B117","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 International Society of Hypertension Global Hypertension Practice Guidelines","volume":"75","year":"2020","journal-title":"Hypertension"},{"issue":"1","key":"key20230322060814_B118","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/HYPERTENSIONAHA.121.17596","article-title":"Nonadherence in hypertension: How to develop and implement chemical adherence testing","volume":"79","year":"2022","journal-title":"Hypertension"},{"issue":"1","key":"key20230322060814_B119","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/bcp.13402","article-title":"Medication adherence in patients with apparent resistant hypertension: Fndings from the SYMPATHY trial","volume":"84","year":"2018","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"11","key":"key20230322060814_B120","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1111\/bcp.13706","article-title":"Therapeutic drug monitoring\u2013guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence","volume":"84","year":"2018","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"1","key":"key20230322060814_B121","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/HYPERTENSIONAHA.120.15038","article-title":"Clinical applicability of monitoring antihypertensive drug levels in blood","volume":"76","year":"2020","journal-title":"Hypertension"},{"issue":"4","key":"key20230322060814_B122","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/jhh.2016.69","article-title":"Detecting non-adherence by urine analysis in patients with uncontrolled hypertension: Rates, reasons and reactions","volume":"31","year":"2017","journal-title":"Journal of Human Hypertension"},{"issue":"3","key":"key20230322060814_B123","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/FTD.0b013e3181dca295","article-title":"Perspectives of liquid chromatography coupled to low- and high-resolution mass spectrometry for screening, identification, and quantification of drugs in clinical and forensic toxicology","volume":"32","year":"2010","journal-title":"Therapeutic Drug Monitoring"},{"issue":"5","key":"key20230322060814_B124","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00216-012-5726-z","article-title":"Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control","volume":"403","year":"2012","journal-title":"Analytical and Bioanalytical Chemistry"},{"issue":"1\u20132","key":"key20230322060814_B125","first-page":"147","article-title":"Simultaneous determination of 6 beta-blockers, 3 calcium-channel antagonists, 4 angiotensin-II antagonists and 1 antiarrhytmic drug in post-mortem whole blood by automated solid phase extraction and liquid chromatography mass spectrometry: Method development and robustness testing by experimental design","volume":"850","year":"2007","journal-title":"Journal of Chromatography B"},{"issue":"1\u20132","key":"key20230322060814_B126","first-page":"169","article-title":"Screening for library-assisted identification and fully validated quantification of 22 beta-blockers in blood plasma by liquid chromatography\u2013mass spectrometry with atmospheric pressure chemical ionization","volume":"1058","year":"2004","journal-title":"Journal of Chromatography A"},{"issue":"6","key":"key20230322060814_B127","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2337\/dc06-0255","article-title":"Assessment of patients\u2019 and physicians\u2019 compliance to an ACE inhibitor treatment based on urinary N-acetyl Ser-Asp-Lys-Pro determination in the Noninsulin-Dependent Diabetes, Hypertension, Microalbuminuria, Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR) study","volume":"29","year":"2006","journal-title":"Diabetes Care"},{"issue":"8","key":"key20230322060814_B128","article-title":"Benefit of serum drug monitoring complementing urine analysis to assess adherence to antihypertensive drugs in first-line therapy","volume":"15","year":"2020","journal-title":"PLOS One"},{"key":"key20230322060814_B129","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.aca.2015.08.018","article-title":"Orbitrap technology for comprehensive metabolite-based liquid chromatographic\u2013high resolution-tandem mass spectrometric urine drug screening\u2014Exemplified for cardiovascular drugs","volume":"891","year":"2015","journal-title":"Analytica chimica acta"},{"key":"key20230322060814_B130","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jpba.2017.05.018","article-title":"UHPLC-MS\/MS method with sample dilution to test therapeutic adherence through quantification of ten antihypertensive drugs in urine samples","volume":"142","year":"2017","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"key20230322060814_B131","first-page":"3244","article-title":"A non-invasive method for detection of antihypertensive drugs in biological fluids: The salivary therapeutic drug monitoring","volume":"12","year":"2022","journal-title":"Frontiers in Pharmacology"},{"key":"key20230322060814_B132","first-page":"99","article-title":"Bisoprolol, ramipril and simvastatin determination in dried blood spot samples using LC-HRMS for assessing medication adherence","volume":"81","year":"2013","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"issue":"1","key":"key20230322060814_B133","first-page":"1","article-title":"LC-HRMS analysis of dried blood spot samples for assessing adherence to cardiovascular medications","volume":"7","year":"2015","journal-title":"Journal of Bioanalysis & Biomedicine"},{"issue":"11","key":"key20230322060814_B134","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s40262-014-0177-7","article-title":"Therapeutic drug monitoring by dried blood spot: Progress to date and future directions","volume":"53","year":"2014","journal-title":"Clinical Pharmacokinetics"},{"issue":"3","key":"key20230322060814_B135","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/FTD.0b013e31819e91ce","article-title":"Dried blood spot methods in therapeutic drug monitoring: Methods, assays, and pitfalls","volume":"31","year":"2009","journal-title":"Therapeutic Drug Monitoring"},{"issue":"5","key":"key20230322060814_B136","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/dta.1646","article-title":"Dried blood spots: Concepts, present status, and future perspectives in bioanalysis","volume":"6","year":"2014","journal-title":"Drug testing and Analysis"},{"key":"key20230322060814_B137","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/B978-0-12-805463-5.00002-X","volume-title":"Analytical chemistry for assessing medication adherence","year":"2016"},{"issue":"3","key":"key20230322060814_B138","first-page":"225","article-title":"Serum uric acid predicts antihypertensive medication adherence in Nigeria: A hospital based study","volume":"37","year":"2020","journal-title":"West African Journal of Medicine"},{"issue":"10","key":"key20230322060814_B139","doi-asserted-by":"crossref","first-page":"887","DOI":"10.7196\/SAMJ.2017.v107i10.12268","article-title":"Therapeutic drug monitoring of amlodipine and the Z-FHL\/HHL ratio: Adherence tools in patients referred for apparent treatment-resistant hypertension","volume":"107","year":"2017","journal-title":"South African Medical Journal"},{"key":"key20230322060814_B140","article-title":"Concentrations of efavirenz in hair are strongly correlated with virologic response","year":"2009","journal-title":"16th Conference on Retroviruses and Opportunistic Infections (CROI)"},{"issue":"1\u20133","key":"key20230322060814_B141","first-page":"93","article-title":"The incorporation of dyes into hair as a model for drug binding","volume":"107","year":"2000","journal-title":"Forensic Science International"},{"issue":"7","key":"key20230322060814_B142","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/j.1552-4604.1992.tb05780.x","article-title":"Hair analysis of cocaine: Differentiation between systemic exposure and external contamination","volume":"32","year":"1992","journal-title":"Journal of Clinical Pharmacology"},{"issue":"2","key":"key20230322060814_B143","article-title":"Association of anti-tuberculosis drug concentrations in hair and treatment outcomes in MDR-and XDR-TB","volume":"5","year":"2019","journal-title":"ERJ Open Research"},{"key":"key20230322060814_B144","doi-asserted-by":"crossref","first-page":"121729","DOI":"10.1016\/j.jchromb.2019.121729","article-title":"Simultaneous analysis of 11 medications for drug resistant TB in small hair samples to quantify adherence and exposure using a validated LC-MS\/MS panel","volume":"1125","year":"2019","journal-title":"Journal of chromatography B, Analytical Technologies in the Biomedical and Life Sciences"},{"key":"key20230322060814_B145","article-title":"Validated LC-MS\/MS panel for quantifying 11 drug-resistant TB medications in small hair samples","volume":"159","year":"2020","journal-title":"JoVE (Journal of Visualized Experiments)"},{"issue":"3","key":"key20230322060814_B146","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0379-0738(99)00024-9","article-title":"Testing for anabolic steroids in hair from two bodybuilders","volume":"101","year":"1999","journal-title":"Forensic Science International"},{"issue":"2","key":"key20230322060814_B147","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00228-016-2163-5","article-title":"Monitoring of adherence to headache treatments by means of hair analysis","volume":"73","year":"2017","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"1","key":"key20230322060814_B148","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10461-019-02460-5","article-title":"Antiretroviral concentration in hair as a measure for antiretroviral medication adherence: A systematic review of global literature","volume":"24","year":"2020","journal-title":"AIDS and Behavior"},{"issue":"10","key":"key20230322060814_B149","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/cid\/cir131","article-title":"Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy","volume":"52","year":"2011","journal-title":"Clinical Infectious Diseases"},{"issue":"5","key":"key20230322060814_B150","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/QAI.0b013e31829c48ad","article-title":"Hair and plasma data show that lopinavir, ritonavir and efavirenz all transfer from mother to infant in utero, but only efavirenz transfers via breastfeeding","volume":"63","year":"2013","journal-title":"Journal of Acquired Immune Deficiency Syndromes (1999)"},{"issue":"4","key":"key20230322060814_B151","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/QAI.0b013e31820dc0cc","article-title":"Low lopinavir plasma or hair concentrations explain second line protease inhibitor failures in a resource-limited setting","volume":"56","year":"2011","journal-title":"Journal of Acquired Immune Deficiency Syndromes (1999)"},{"issue":"21","key":"key20230322060814_B152","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1002\/rcm.3750","article-title":"Sensitive analysis of anti-HIV drugs, efavirenz, lopinavir and ritonavir, in human hair by liquid chromatography coupled with tandem mass spectrometry","volume":"22","year":"2008","journal-title":"Rapid Communications in Mass Spectrometry: An International Journal Devoted to the Rapid Dissemination of Up-to-the-Minute Research in Mass Spectrometry"},{"key":"key20230322060814_B153","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.2147\/DDDT.S214907","article-title":"Minoxidil and its use in hair disorders: A review","volume":"13","year":"2019","journal-title":"Drug Design, Development and Therapy"},{"key":"key20230322060814_B154","doi-asserted-by":"crossref","first-page":"100050","DOI":"10.1016\/j.medidd.2020.100050","article-title":"Simultaneous determination of minoxidil and minoxidil sulfate by high-performance liquid chromatography with UV-detection and its applications","volume":"7","year":"2020","journal-title":"Medicine in Drug Discovery"},{"issue":"5","key":"key20230322060814_B155","first-page":"250","article-title":"Association of blood and hair mercury with blood pressure and vascular reactivity","volume":"108","year":"2009","journal-title":"WMJ: Official Publication of the State Medical Society of Wisconsin"},{"issue":"1","key":"key20230322060814_B156","article-title":"Evaluation of mineral status in hypertensive patients undergoing pharmacotherapy","volume":"66","year":"2015","journal-title":"Roczniki Pa\u0144stwowego Zak\u0142adu Higieny"},{"issue":"1","key":"key20230322060814_B157","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/dta.2445","article-title":"First identification of a diuretic, hydrochlorothiazide, in hair: Application to a doping case and interpretation of the results","volume":"11","year":"2019","journal-title":"Drug Testing and Analysis"},{"issue":"1","key":"key20230322060814_B158","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1520\/JFS14654J","article-title":"Doping control for beta-adrenergic compounds through hair analysis","volume":"45","year":"2000","journal-title":"Journal of Forensic Sciences"},{"issue":"8","key":"key20230322060814_B159","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/dta.3055","article-title":"Development and validation of a fast ultra high-performance liquid chromatography tandem mass spectrometry (UHPLC-MS\/MS) method for determining carbonic anhydrase inhibitors and their metabolites in urine and hair","volume":"13","year":"2021","journal-title":"Drug Testing and Analysis"},{"issue":"6","key":"key20230322060814_B160","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00769-011-0775-0","article-title":"Practical aspects concerning validation and quality control for forensic and clinical bioanalytical quantitative methods","volume":"16","year":"2011","journal-title":"Accreditation and Quality Assurance"},{"issue":"7","key":"key20230322060814_B161","article-title":"Factors associated with poor adherence to medication among hypertensive patients in twelve low and middle income Sub-Saharan countries","volume":"14","year":"2019","journal-title":"PLOS One"},{"issue":"3","key":"key20230322060814_B162","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/QAI.0000000000000154","article-title":"Antiretroviral concentrations in small hair samples as a feasible marker of adherence in rural Kenya","volume":"66","year":"2014","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"1","key":"key20230322060814_B163","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/aid.2013.0239","article-title":"Short communication: A low-cost method for analyzing nevirapine levels in hair as a marker of adherence in resource-limited settings","volume":"30","year":"2014","journal-title":"AIDS Research and Human Retroviruses"},{"issue":"17","key":"key20230322060814_B164","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1161\/CIRCULATIONAHA.121.057631","article-title":"Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease","volume":"145","year":"2022","journal-title":"Circulation"},{"issue":"5","key":"key20230322060814_B165","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1161\/HYPERTENSIONAHA.118.11227","article-title":"Cost-utility of an objective biochemical measure to improve adherence to antihypertensive treatment","volume":"72","year":"2018","journal-title":"Hypertension"},{"issue":"11","key":"key20230322060814_B166","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1007\/s00204-022-03343-w","article-title":"One-step extraction and determination of 513 psychoactive substances, drugs, and their metabolites from hair by LC-MS\/MS","volume":"96","year":"2022","journal-title":"Archives of Toxicology"},{"issue":"1","key":"key20230322060814_B167","first-page":"1","article-title":"Forensic toxicological analysis of hair: A review","volume":"9","year":"2019","journal-title":"Egyptian Journal of Forensic Sciences"},{"key":"key20230322060814_B168","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jchromb.2018.03.021","article-title":"Simultaneous determination of antiretroviral drugs in human hair with liquid chromatography\u2013electrospray ionization\u2013tandem mass spectrometry","volume":"1083","year":"2018","journal-title":"Journal of Chromatography B"},{"key":"key20230322060814_B169","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pupt.2018.07.001","article-title":"Hair analysis to monitor adherence to prescribed chronic inhaler drug therapy in patients with asthma or COPD","volume":"51","year":"2018","journal-title":"Pulmonary Pharmacology & Therapeutics"},{"key":"key20230322060814_B170","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.forsciint.2017.11.004","article-title":"Role of hair pigmentation in drug incorporation into hair","volume":"281","year":"2017","journal-title":"Forensic Science International"}],"container-title":["Global Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/storage.googleapis.com\/jnl-up-j-gh-files\/journals\/1\/articles\/1191\/submission\/proof\/1191-1-5850-1-10-20230322.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T10:41:39Z","timestamp":1782816099000},"score":1,"resource":{"primary":{"URL":"https:\/\/globalheartjournal.com\/articles\/10.5334\/gh.1191\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":170,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3,22]]}},"alternative-id":["10.5334\/gh.1191"],"URL":"https:\/\/doi.org\/10.5334\/gh.1191","relation":{},"ISSN":["2211-8179"],"issn-type":[{"value":"2211-8179","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"17"}}